What Is the Molecular Diagnosis Trend in the Future?

A More Accessible and Flexible Solution—Molecular POCT and Rich Menus

Thursday, July 28
12 – 12:20 p.m.
Exhibit Hall Theater 1
Presentation by Sansure Biotech Inc.


Since the COVID-19 outbreak, the industry has increasingly recognized the importance of accurate, rapid, and rigorous diagnosis. POCT is a kind of detection method that does not require high professional requirements for laboratories and personnel, is easy to obtain, and is also more cost-effective. With the advancement of technology, more and more testing can be carried out under POCT conditions, especially with molecular diagnosis. Sansure Biotech Inc., as an innovative IVD company, is developing more comprehensive POCT application scenarios and inspection projects, from respiratory infection identification to HPV screening and much more.


After attending this session, participants will be able to:

  • Know more about the importance of molecular diagnosis.
  • See more possible projects to carry out on POCT systems.